Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Jul 26, 2017

Total Value ($000): $160,239 (100.0% shares, 0.0% debt)

Holdings (11)

— Paratek Pharmaceuticals 39.1%

Value ($000) $62,670 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Juno Therapeutics 22.9%

Value ($000) $36,750 Shares 1,229,512 Est. Cost $52.22 Unrealized —

— FibroGen 12.6%

Value ($000) $20,268 Shares 627,492 Est. Cost $27.34 Unrealized —

— Nabriva Therapeutics 7.4%

Value ($000) $11,937 Shares 1,139,035 Est. Cost $10.48 Unrealized —

— Jounce Therapeutics 5.1%

Value ($000) $8,132 Shares 579,650 Est. Cost $21.99 Unrealized —

— Pieris Pharmaceuticals 4.3%

Value ($000) $6,918 Shares 1,367,253 Est. Cost $1.83 Unrealized —

— Egalet 4.3%

Value ($000) $6,849 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— Cidara Therapeutics 2.1%

Value ($000) $3,337 Shares 444,965 Est. Cost $10.40 Unrealized —

— CymaBay Therapeutics 1.1%

Value ($000) $1,737 Shares 301,477 Est. Cost $1.94 Unrealized —

— ESSA Pharma 0.6%

Value ($000) $933 Shares 1,696,969 Est. Cost $5.22 Unrealized —

— Dicerna Pharmaceuticals 0.4%

Value ($000) $708 Shares 223,457 Est. Cost $16.47 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Paratek Pharmaceuticals	2,600,410	$62,670	39.1%	$34.18	—	Common Stock	699374302
—	Juno Therapeutics	1,229,512	$36,750	22.9%	$52.22	—	Common Stock	48205A109
—	FibroGen	627,492	$20,268	12.6%	$27.34	—	Common Stock	31572Q808
—	Nabriva Therapeutics	1,139,035	$11,937	7.4%	$10.48	—	Common Stock	G63637105
—	Jounce Therapeutics	579,650	$8,132	5.1%	$21.99	—	Common Stock	481116101
—	Pieris Pharmaceuticals	1,367,253	$6,918	4.3%	$1.83	—	Common Stock	720795103
—	Egalet	2,889,926	$6,849	4.3%	$5.98	—	Common Stock	28226B104
—	Cidara Therapeutics	444,965	$3,337	2.1%	$10.40	—	Common Stock	171757107
—	CymaBay Therapeutics	301,477	$1,737	1.1%	$1.94	—	Common Stock	23257D103
—	ESSA Pharma	1,696,969	$933	0.6%	$5.22	—	Common Stock	29668H104
—	Dicerna Pharmaceuticals	223,457	$708	0.4%	$16.47	—	Common Stock	253031108